Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Current Leases (2019 - 2025)

Sanofi's Current Leases history spans 7 years, with the latest figure at $316.6 million for Q4 2025.

  • For Q4 2025, Current Leases rose 13.52% year-over-year to $316.6 million; the TTM value through Dec 2025 reached $316.6 million, up 13.52%, while the annual FY2025 figure was $307.3 million, 8.79% up from the prior year.
  • Current Leases for Q4 2025 was $316.6 million at Sanofi, up from $278.9 million in the prior quarter.
  • Across five years, Current Leases topped out at $316.6 million in Q4 2025 and bottomed at $278.9 million in Q4 2024.
  • The 5-year median for Current Leases is $295.9 million (2023), against an average of $296.3 million.
  • The largest annual shift saw Current Leases dropped 8.16% in 2022 before it grew 13.52% in 2025.
  • A 5-year view of Current Leases shows it stood at $307.7 million in 2021, then dropped by 8.16% to $282.6 million in 2022, then rose by 4.7% to $295.9 million in 2023, then decreased by 5.74% to $278.9 million in 2024, then grew by 13.52% to $316.6 million in 2025.
  • Per Business Quant, the three most recent readings for SNY's Current Leases are $316.6 million (Q4 2025), $278.9 million (Q4 2024), and $295.9 million (Q4 2023).